Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cipherome

Explore full profile

AI-driven data analysis platform enhancing healthcare research with predictive analytics, cohort querying, and automated summaries

San Jose, United StatesFounded 2015Health
Valuation $50–100M Last recorded · 2022
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cipherome and the history behind them.

About Cipherome

Cipherome operates in the healthcare and biotechnology sectors, focusing on leveraging artificial intelligence (AI) to enhance data analysis and research capabilities. The company serves healthcare providers, researchers, and pharmaceutical companies by offering a comprehensive data analysis platform known as COMPASS. This platform enables users to train AI models effortlessly, conduct statistical tests without coding, and define patient cohorts with precision. By automating tasks such as summarizing lengthy documents and generating social media posts, Cipherome aims to accelerate the research process and improve evidence-based decision-making. The business model is primarily subscription-based, generating revenue through platform access fees and premium features. Cipherome's market includes academic institutions, clinical research organizations, and biotech firms looking to optimize their data-driven research efforts.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
San Jose, United States
Employees
12
Open positions
None listed
Dealroom signal
59.5/100
Industry
Health
Sector
Health, Biotechnology, Medical Data, Techbio, Hard Tech
Client focus
b2b

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Feb 2022 $16M $65M Medivate Partners · InterVest · SIGNITE PARTNERS · Nautilus ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Cipherome website traffic

Latest recorded traffic for Cipherome is 490 monthly website visits, down 55.5% over the last three months. Cipherome's team declined 20% over the past year.

Latest monthly visits490 3-month web change-55.5% 1-year team growth-20%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Medivate Partners
  • InterVest
  • SIGNITE PARTNERS
  • Nautilus

Other known investors1 additional known investor

  • Nautilus Venture Partners
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States71.4%
🇰🇷 South Korea14.3%
🇵🇭 Philippines14.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cipherome on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cipherome’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.